There are numerous studies published in the peer reviewed medical literature that indicate associations of the standard western diet, low vitamin D levels and higher omega 3 / omega 6 fatty acid ratios with cancer cell behavior.
Prostate cancer studies suggest higher Gleason score biopsy results, higher PSA levels and higher stage prostate cancer at the time of diagnosis are associated with lower circulating vitamin D levels.
Additionally, serum omega 3/6 fatty acid ratios have been associated with more aggressive cancer cell behavior. Also, turmeric curcumin has been shown to play a potentially significant role in multiple cancer cell biochemical pathways, as has Zyflamend, a ten polyherbal compound.
Below is a component of a dietary intervention and supplement program for people diagnosed with or at risk for prostate cancer based on elevated PSA and or family history of prostate cancer as well as for people with or at risk for colon cancer and breast cancer.
At the time of enrollment the patients are given a comprehensive diet regimen. In addition, vitamin D, omega 3 fatty acid and turmeric curcumin supplementation is initiated and a variety of blood work is obtained.
The nutritional supplements are administered in a controlled manner based on blood test results, in an effort to impact on the biology of the disease process. Vitamin D supplementation is directed at serum target levels, and omega 3 fatty acid supplementation is directed at achieving a serum omega 3:6 ratio of 1:5, (standard American diet ratios are 1:10 – 1:20).
The following is based on 8 years of treating over 600 patients with elevated PSA, family history of prostate cancer, or who have already been treated for prostate cancer many of whom have shown benefit from the program with no adverse side effects reported.
INCLUSION OF DIETARY SUPPLEMENTS AS MARKED